Generating custom antibodies for bioanalytical research: an interview with Ulrich Mayer
In this interview Ulrich Mayer, Technical Sales Specialist (Bio-Rad Laboratories, CA, USA) discusses Bio-Rad’s custom recombinant antibody generation capabilities. Mayer explains why global biopharmaceutical companies and CROs choose Bio-Rad for the generation of custom antibodies targeting different types of large molecule drugs and CAR-T cell therapies. Mayer also describes the technology behind Bio-Rad’s custom antibody service, as well as commenting on what the future may hold for the partnership between Bio-Rad and bioanalytical scientists.
Q How does Bio-Rad help bioanalysts with the challenges of drug development?
Q Why do global biopharma and CROs choose Bio-Rad for the generation of custom antibodies?
Q How does Bio-Rad make anti-idiotypic antibodies?
Q What does the future hold for the partnership between Bio-Rad and bioanalytical scientists?
